Board of Directors

Dr Chris Hand is co-founder of Abingdon Health. He has 30 years’ experience in the medical diagnostics industry in the development and commercialisation of immunodiagnostic products, particularly rapid tests. Chris co-founded the medical diagnostics company Cozart Bioscience Ltd specialising in saliva drug testing, and was Chief Executive of Cozart plc, following IPO on AIM in 2004, until October 2007 when the company was sold to Concateno plc. Prior to founding Cozart, Chris was Director of Research for the European base of DPC (now part of Siemens Healthcare Solutions) developing a wide range of immunodiagnostic kits in a variety of formats.

He has a BSc in Applied Biochemistry from Brunel University and a DPhil from the Faculty of Medicine, University of Oxford.

Chris Yates joined Abingdon Health as CEO in July 2015. Chris had originally co-founded Abingdon Health with Dr Chris Hand and Dr Brett Pollard in 2008 and had been a non-executive of the Company prior to his appointment as CEO. Prior to Abingdon Health, Chris held CFO positions in two medical diagnostic group’s, both AIM-listed, Immunodiagnostic Systems Holdings PLC and Cozart plc.

Melanie is a highly experienced executive with a strong track record of process and business improvement, and has broad experience in managing rapidly growing businesses, fund raisings, acquisitions, and corporate governance. Most recently she was Group Finance Director at GVO-B1 Ltd, and prior to that served as Chief Financial Officer and Chief Operating Officer at AIM-listed Surgical Innovations Group Plc where she was instrumental in leading the Company to profitability. Melanie holds a BA (Hons) in Accounting and Finance from the Nottingham Trent University.

Mary is the Senior Independent NED of Abingdon Health and Chair of the Audit Committee. Mary has extensive experience in the healthcare sector, having previously been Chief Financial Officer and Board member of AIM listed Advanced Medical Solutions plc (AMS) for 19 years during which the company saw 15 years of consecutive growth. Mary is a Member of the Chartered Institute of Management Accountants (ACMA) and a Fellow of the Association of Corporate Treasurers (FCT). She has a degree in Chemistry from the University of Oxford.